Sectors
CEOs Fight for Elan, the Biggest Hostile Bid of the Year
Since February, top executives of Elan and Royalty Pharma have been vying to control over Elan. (Photo : Reuters )Irish drugmaker Elan will be giving back $1 billion to shareholders as a boost from the sale of its stake in multiple sclerosis treatment Tysabri to partner Biogen Idec.
Lincoln Benefit Life eyed by TPG, Resolution, and J.C. Flowers
Three firms are setting its sights on Allstate Cor's Lincoln Benefit Life. (Photo : TPG Capital)TPG Headquarters at 101 Collins Street Private equity firms J.
Indiana Public Retirement System chooses Carlyle and AlpInvest to manage IIF-I
INPRS chose the Carlyle Group and AlpInvest as managers of a combined $305 million worth of investment fund.
Elan to sell off itself
Elan Pharmaceuticals has decided to sell itself after the many tendered offers it has received. (Photo : Reuters)The image is the logo of Elan Pharmaceuticals.




